Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
8
currently held
Exits tracked
3
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin11 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
HilleVax Abingworth Bioventures 8 | Abingworth | 2021 | 4yr | Exited 2025 | XOMA Royalty | – | |||
Phathom Pharmaceuticals Abingworth Bioventures VII | Abingworth | 2019 | 0yr | Exited 2019 | – | – | |||
Medpace Cinven Fifth Fund | Cinven | 2014 | 3yr | Exited 2017 | Medpace Holdings Inc. | – | |||
Alira Health Creadev | Creadev International | 2021 | 5yr | Active | – | – | |||
Exer Quilvest Capital Partners Direct PE Club Fund I | Quilvest Capital Partners | 2019 | 7yr | Active | – | – | |||
Petfolk White Star Capital Fund III | White Star Capital | 2021 | 5yr | Active | – | – | |||
Provect AI. Newfund HEKA | Newfund Management | 2024 | 2yr | Active | – | – | |||
Triple Ring Technologies Mérieux Innovation 1 | Merieux Equity Partners | 2020 | 6yr | Active | – | – | |||
Venatorx Pharmaceuticals Abingworth Bioventures VI | Abingworth | 2022 | 4yr | Active | – | – | |||
DUX Healthcare Newfund HEKA | Newfund Management | 2025 | 1yr | Active | – | – | |||
Sarnova Patricia Industries | Patricia Industries | 2018 | 8yr | Active | – | – |
HilleVax
Abingworth Bioventures 8
USSector
Healthcare
InvestorAbingworth
Entry
2021
Hold
4yr
Exit
2025
to XOMA Royalty
Phathom Pharmaceuticals
Abingworth Bioventures VII
USSector
Healthcare
InvestorAbingworth
Entry
2019
Hold
0yr
Exit
2019
Medpace
Cinven Fifth Fund
USSector
Healthcare
InvestorCinven
Entry
2014
Hold
3yr
Exit
2017
to Medpace Holdings Inc.
Alira Health
Creadev
USSector
Healthcare
InvestorCreadev International
Entry
2021
Hold
5yr
Exer
Quilvest Capital Partners Direct PE Club Fund I
USSector
Healthcare
InvestorQuilvest Capital Partners
Entry
2019
Hold
7yr
Petfolk
White Star Capital Fund III
USSector
Healthcare
InvestorWhite Star Capital
Entry
2021
Hold
5yr
Provect AI.
Newfund HEKA
USSector
Healthcare
InvestorNewfund Management
Entry
2024
Hold
2yr
Triple Ring Technologies
Mérieux Innovation 1
USSector
Healthcare
InvestorMerieux Equity Partners
Entry
2020
Hold
6yr
Venatorx Pharmaceuticals
Abingworth Bioventures VI
USSector
Healthcare
InvestorAbingworth
Entry
2022
Hold
4yr
DUX Healthcare
Newfund HEKA
USSector
Healthcare
InvestorNewfund Management
Entry
2025
Hold
1yr
Sarnova
Patricia Industries
USSector
Healthcare
InvestorPatricia Industries
Entry
2018
Hold
8yr